Physician profile
Loan K Lam
NPI 1386866077
$72,114.61
in general payments reported to CMS, 2019-2025
30 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $416 · 2021: $696 · 2022: $3,828 · 2023: $1,771 · 2024: $18K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Travel and Lodging: $19K · Food and Beverage: $6,450 · Consulting Fee: $4,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,110.00 |
| Travel and Lodging | $18,681.58 |
| Food and Beverage | $6,449.62 |
| Consulting Fee | $4,785.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $51,583.64 | 2021-2025 | Nuzyra |
| Organogenesis INC. | $8,665.36 | 2019-2025 | Novachor, Affinity, Nushield |
| Hartmann USA, INC. | $2,684.11 | 2021-2025 | Zetuvit Plus 10x10 P10 |
| Kerecis Limited | $1,693.14 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Urgo Medical North America, LLC | $1,393.66 | 2022-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Lifenet Health | $1,364.76 | 2025 | Theragenesis Wound Matrix |
| Ets Wound Care LLC | $1,012.08 | 2022-2025 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $866.70 | 2019-2025 | Collagenase Santyl, Grafix Pl, Renasys Touch |
| Kci USA, INC. | $657.22 | 2019-2023 | 3m Coban, Activ.A.C. |
| Boston Scientific Corporation | $598.37 | 2022-2025 | General - Pain Management, Jetstream Sc, Ranger |
| Nuo Therapeutics | $280.86 | 2023-2025 | |
| Tactile Systems Technology INC | $197.50 | 2020-2022 | |
| Convatec INC. | $179.43 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $145.58 | 2021-2022 | |
| Melinta Therapeutics, LLC | $87.29 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reddress USA, INC. | $86.47 | 2024 | |
| Reprise Biomedical, INC. | $78.43 | 2023-2024 | Miro3d |
| Allergan, INC. | $78.04 | 2019-2020 | |
| Abbvie INC. | $70.01 | 2021-2025 | |
| Stryker Corporation | $60.20 | 2024 | Viaflow |
| Triad Life Sciences INC. | $51.56 | 2022 | |
| Medline Industries LP | $50.53 | 2019-2020 | |
| Bsn Medical INC | $44.10 | 2024 | |
| Nabriva Therapeutics, Plc | $38.02 | 2022 | |
| Advanced Oxygen Therapy INC. | $32.53 | 2023 | Topical Oxygen Chamber For Extremities |
| Cashflow Solutions, LLC | $29.54 | 2022-2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Hydrofera LLC | $25.20 | 2024 | Hydrofera Blue |
| Next Science LLC | $25.17 | 2023 | Blastx, Xperience, Surgx |
| Integra Lifesciences Corporation | $21.24 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loan Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.